OXBDF
Price
$7.91
Change
-$0.35 (-4.24%)
Updated
Sep 24 closing price
Capitalization
926.35M
TBPH
Price
$14.07
Change
+$0.28 (+2.03%)
Updated
Sep 26 closing price
Capitalization
708.58M
39 days until earnings call
Interact to see
Advertisement

OXBDF vs TBPH

Header iconOXBDF vs TBPH Comparison
Open Charts OXBDF vs TBPHBanner chart's image
Oxford Biomedica
Price$7.91
Change-$0.35 (-4.24%)
Volume$100
Capitalization926.35M
Theravance Biopharma
Price$14.07
Change+$0.28 (+2.03%)
Volume$309.11K
Capitalization708.58M
OXBDF vs TBPH Comparison Chart in %
Loading...
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OXBDF vs. TBPH commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OXBDF is a Buy and TBPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (OXBDF: $7.91 vs. TBPH: $14.06)
Brand notoriety: OXBDF and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OXBDF: 9% vs. TBPH: 25%
Market capitalization -- OXBDF: $945.81M vs. TBPH: $694.48M
OXBDF [@Biotechnology] is valued at $945.81M. TBPH’s [@Biotechnology] market capitalization is $694.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OXBDF’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • OXBDF’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, TBPH is a better buy in the long-term than OXBDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OXBDF’s TA Score shows that 2 TA indicator(s) are bullish while TBPH’s TA Score has 4 bullish TA indicator(s).

  • OXBDF’s TA Score: 2 bullish, 2 bearish.
  • TBPH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both OXBDF and TBPH are a good buy in the short-term.

Price Growth

OXBDF (@Biotechnology) experienced а +1.74% price change this week, while TBPH (@Biotechnology) price change was +1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

TBPH is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OXBDF($926M) has a higher market cap than TBPH($709M). TBPH YTD gains are higher at: 49.522 vs. OXBDF (46.525).
OXBDFTBPHOXBDF / TBPH
Capitalization926M709M131%
EBITDAN/A46.1M-
Gain YTD46.52549.52294%
P/E RatioN/A58.63-
RevenueN/A77.2M-
Total CashN/A339M-
Total DebtN/A46.5M-
FUNDAMENTALS RATINGS
OXBDF vs TBPH: Fundamental Ratings
OXBDF
TBPH
OUTLOOK RATING
1..100
9668
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9581
PRICE GROWTH RATING
1..100
3740
P/E GROWTH RATING
1..100
9835
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TBPH's Valuation (72) in the Pharmaceuticals Other industry is in the same range as OXBDF (78) in the null industry. This means that TBPH’s stock grew similarly to OXBDF’s over the last 12 months.

TBPH's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as OXBDF (100) in the null industry. This means that TBPH’s stock grew similarly to OXBDF’s over the last 12 months.

TBPH's SMR Rating (81) in the Pharmaceuticals Other industry is in the same range as OXBDF (95) in the null industry. This means that TBPH’s stock grew similarly to OXBDF’s over the last 12 months.

OXBDF's Price Growth Rating (37) in the null industry is in the same range as TBPH (40) in the Pharmaceuticals Other industry. This means that OXBDF’s stock grew similarly to TBPH’s over the last 12 months.

TBPH's P/E Growth Rating (35) in the Pharmaceuticals Other industry is somewhat better than the same rating for OXBDF (98) in the null industry. This means that TBPH’s stock grew somewhat faster than OXBDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OXBDFTBPH
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FESAX11.500.11
+0.97%
First Eagle Small Cap Opportunity A
GMNAX12.000.10
+0.84%
Gabelli Global Mini Mites A
JRSNX13.070.08
+0.62%
JH Adaptive Risk Mgd U.S. Eq N
ADGAX26.330.12
+0.46%
AB Core Opportunities A
WSTYX78.510.11
+0.14%
Macquarie Science and Technology Y

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and SER have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and SER's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
SER - OXBDF
25%
Poorly correlated
-0.20%
XTLB - OXBDF
24%
Poorly correlated
-1.68%
TBPH - OXBDF
24%
Poorly correlated
+2.03%
ATNM - OXBDF
24%
Poorly correlated
+1.26%
YECO - OXBDF
22%
Poorly correlated
N/A
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+2.03%
KYMR - TBPH
49%
Loosely correlated
+4.68%
VERA - TBPH
38%
Loosely correlated
+4.60%
LYRA - TBPH
37%
Loosely correlated
+1.73%
RGNX - TBPH
36%
Loosely correlated
+3.10%
APLS - TBPH
34%
Loosely correlated
+0.68%
More